#PTA Balloon Catheter Global Market | Explore Tumblr Posts and Blogs

factmrblog · 1 year

Text

Exploring Trends and Opportunities in the Normal Balloon Catheter Market

The global balloon catheter market is expected to grow at a moderate pace over the next decade, due to the rising demand for minimally invasive procedures, increased prevalence of vascular diseases, and improvements in quality of product design. Balloon catheters are used to treat various types of conditions within the body, and a variety of catheter types are available for a variety of specialties, such as cardiology, urology, and neurology.

Revenue growth of the market is projected to be driven by the increasing geriatric population, rising awareness about the benefits and technological advancements associated with balloon catheters, increasing prevalence of cardiovascular diseases, and increasing R&D investment by key manufacturers. Moreover, favorable reimbursement policies and rising healthcare expenditure are likely to drive the market over the forecast period.

Download Sample Copy of This Report:

Key Companies Profiled

Abbott Laboratories

Boston Scientific Corporation

Medtronic plc

Terumo Corporation

MicroPort Scientific Corporation

B. Braun Melsungen AG

Meril Life Sciences Pvt. Ltd.

Hexacath

Tokai Medical Products Inc.

Cook Medical INC

Competitive Landscape

Several normal balloon catheter manufacturing companies have implemented merger and acquisition plans to differentiate them as prominent competitors in the market and to increase sales in the worldwide normal balloon catheter market.

PTA balloon manufacturing companies are forming alliances with small businesses to improve their product portfolios and extend their worldwide footprints. Launch of new products is another method used by manufacturers of normal balloon catheters to increase their market share and domination.

Key Segments Covered in Normal Balloon Catheter Industry Research

Raw Material

Polyurethane Normal Balloon Catheters

Nylon Normal Balloon Catheters

Others

Indication

Normal Balloon Catheters for Coronary Artery Disease

Normal Balloon Catheters for Peripheral Vascular Disease

Normal Balloon Catheters for Preventing Blood Vessel Constriction

Normal Balloon Catheters for Percutaneous Coronary Intervention

Others

Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters

Angioplasty Balloon Catheters

End User

Normal Balloon Catheters for Hospitals

Normal Balloon Catheters for Ambulatory Surgical Centers

Normal Balloon Catheters for Cardiac Catheterization Laboratories

Get Full Access of Complete Report: https://www.factmr.com/checkout/147

Queries addressed in the Normal balloon catheter market report:

Why are the Normal balloon catheter market players targeting region for increased product sales?

What patented technologies are the players utilizing in the global Normal balloon catheter market?

Which regions are displaying the fastest growth in the Normal balloon catheter market?

What are the underlying micro- macroeconomic factors affecting the global Normal balloon catheter market?

Contact:US Sales Office : 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 E-Mail: [email protected]

0 notes

roselinel690 · 1 year

Link

#PTA balloon catheter Market PTA balloon catheter Market Trends PTA balloon catheter Market Growth PTA balloon catheter Market Industry PTA b

0 notes

businessinfinity · 1 year

Text

0 notes

jean-perry · 2 years

Text

0 notes

jainm24 · 2 years

Text

PTA Balloon Catheter Market Size, Development and Forecast to 2026

According to the current analysis of Reports and Data, the global Nylon PTA Balloon Catheter Market valued at USD 2.28 billion in 2018 and is expected to reach USD 4.93 billion by the year 2026, at a CAGR of 10%. PTA is known as percutaneous transluminal angioplasty. A Nylon PTA Balloon Catheter comprises of an inflatable balloon at its tip used for minimally invasive catheterization procedure; this procedure is performed to enlarge the narrowed vessel opening.

PTA balloon is used in the treatment of coronary artery disease and Peripheral Vascular Disease, WHO had reported 17.9 million people died in 2016 due to cardiovascular diseases. It includes about 31% of all global deaths. Adaptation to Sedentary lifestyle, habits like lack of physical activity, consumption of alcohol, unhealthy food, smoking, and a rise in the prevalence of obesity, are the major factors driving the market of Nylon PTA Balloon Catheters. Furthermore, an increase in regulatory approvals, product launches, and mergers and acquisitions are expected to fuel the global Nylon PTA Balloon Catheter market in the forecast period. However, alternative therapies and complications associated with serration balloon catheters and upsurge in demand for minimally invasive surgeries are restraining the growth of the market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2644

Further key findings from the report suggest

In the year 2018, the Lutonix DCB catheter was introduced. It was a drug-coated balloon catheter that facilitates the delivery of paclitaxel to the arterial wall with single, short inflation. Paclitaxel is used to treat arterial restenosis. The Lutonix DCB's was found to be a highly effective formulation of paclitaxel it also contains polysorbate and sorbitol that allows Lutonix DCB catheter to deliver a therapeutic dose to the artery wall and also keep the dose as low as possible.

In the year 2019, Freudenberg Medical, a global developer and manufacturer of finished medical devices, components, and minimally invasive solutions for the medical device industry, had initiated for expanding its services in the manufacturing of medical balloon development and balloon rapid prototyping services.

The peripheral vascular disease had held a significant share in the PTA catheter balloon market owing to the rise in smoking, diabetes, obesity, high blood pressure, high cholesterol, and is likely to rise with a CAGR of 9.7% in the forecast period.

PTA catheters mostly are made of Polyurethane, and more than 50% of catheters are made from it as the tubing contains the properties of both rubber and plastic also provide with toughness and tensile strength it is highly biocompatible as it softens at body temperature.

Ambulatory surgical centers had registered a significant market share for achieving better treatment facilities for patients suffering from coronary artery disease and peripheral vascular disease it is likely to grow with a CAGR of 9.8% in the forecast period.

Top Players in the Global Nylon PTA Balloon Catheter Market:

Nylon PTA Balloon Catheter include Medtronic plc; Terumo Corporation; Cardinal Health; Boston Scientific Corporation; Natec Medical; and Surmodics, Inc, Cook Medical, Biotronik, Andratec

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.

To know more about the report @ https://www.reportsanddata.com/report-detail/pta-balloon-catheter-market

Nylon PTA Balloon Catheter Market Segmentation:

Types Outlook (Revenue in Million USD; 2016–2026)

Polyurethane

Nylon

Others

Applications Outlook (Revenue in Million USD; 2017–2024

Coronary Artery Disease

Peripheral Vascular Disease

End-Use Outlook (Revenue in Million USD; 2017–2024)

Hospitals and Clinics

Ambulatory Surgical Centers

Others

Global Nylon PTA Balloon Catheter Market Report: Regional Segmentation

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2644

Read More Reports:

4D Printing in Healthcare Market @ https://www.reportsanddata.com/report-detail/4d-printing-in-healthcare-market

Respiratory Care Devices Market @ https://www.reportsanddata.com/report-detail/respiratory-care-devices-market

Healthcare Personal Protective Equipment (PPE) Market @ https://www.reportsanddata.com/report-detail/healthcare-personal-protective-equipment-market

Astaxanthin Market @ https://www.reportsanddata.com/report-detail/astaxanthin-market

Influenza Diagnostics Market @ https://www.reportsanddata.com/report-detail/influenza-diagnostics-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

0 notes

wemarketresearchreport · 2 years

Text

Angioplasty Balloons Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Angioplasty Balloons Market was worth USD 2,550 million in 2021 and is anticipated to reach a valuation of USD 3,655 million in 2030, expanding at a CAGR of 3.5% over the forecast duration.

One of the important factors driving the market's growth is the rising prevalence of coronary and peripheral artery disorders around the world. In line with this, the growing elderly population, as well as people suffering from obesity and high cholesterol levels, are boosting market growth. Furthermore, drug-coated angioplasty balloons are becoming more popular because they provide higher safety, effectiveness, and enhanced blood flow throughout the body. This has also reduced the use of stents and other vessel implants that can cause vessel breakage. Various technological improvements, such as the development of imaging technologies and the introduction of novel versions that can be implanted without the use of general anaesthesia, are also causing significant growth. Increasing public health awareness

Superior technological advancements such as progressive flexibility due to innovations in hydrophilic design, superior hydrophilic coatings, improved performance under high pressure due to added pushability, and robust design reducing friction are expected to drive the global percutaneous transluminal angioplasty balloons market growth during the forecast period. Rising reimbursement coverage for the treatment of cardiac diseases, especially among end-users in developing countries (which have a relatively higher patient population), are some of the factors likely to drive the growth of the global percutaneous transluminal angioplasty balloons market between 2017 and 2025. However, the danger of patient pain during balloon inflation and the likelihood of restenosis are two considerations that are likely to influence the decision.

Request a sample copy of Angioplasty Balloons Market: https://wemarketresearch.com/sample-request/angioplasty-balloons-market/42/

PTA Balloons are a technique in which a little flexible catheter with a very small diameter of a few millimetres is introduced into an artery and steered to the desired region where the blood vessel has narrowed due to some sort of cardiovascular disease.

A tiny balloon is inflated at the end of the catheter when it reaches the appropriate place, squeezing the blocking component responsible for a narrow artery against the blood vessel wall and restoring normal blood flow.

The PTCA balloon catheters market is predicted to develop as the population ages and lifestyle changes lead to hypertension, obesity, and other risk factors that lead to vascular illnesses. Furthermore, technological developments, including the FDA's reclassification of several PTCA catheters from class III to class II devices, as well as an increase in the prevalence of cardiovascular illnesses, are projected to fuel market expansion. Alternative therapy are available, but risks associated with PTCA balloon catheters limit this progress. During the projection period, the rising demand for minimally invasive operations, rising disposable incomes, and growth prospects in Asia-Pacific and Latin America are likely to present significant chances for market expansion.

Global Angioplasty Balloons Market- Segmental Analysis

By Material

• Nylon

• Polyurethane

• Silicone urethane co-polymers

• Other

By Type

• Plain old balloon angioplasty

• Drug coated balloon angioplasty

• Cutting balloons

• Scoring balloons

• Stent graft balloon catherer

By disease

• Coronary angioplasty

• Venous angioplasty

• Carotid angioplasty

• Renal Artery angioplasty

• Peripheral Angioplasty

By End User

• Cardiac Catheterization Laboratories

• Hospitals

• Specialty Clinics

• Ambulatory Surgery Centers

• Diagnostic Centers

Global Angioplasty Balloons Market- End User Segment Analysis

By Application

• Coronary

• Peripheral

Purchase Global Angioplasty Balloonss Market Research Report:- https://wemarketresearch.com/purchase/angioplasty-balloons-market/42/?license=single

Global Angioplasty Balloons Market- Competitive Landscape

Major players constituting the competitive hierarchy of this market sphere are Abbott Laboratories, Becton, Dickinson, and Company, B. Braun Melsungen AG, Endocor GmbH, Koninklijke Philips NV, Medtronic Plc, Oscor, Inc, Terumo Corporation, Boston Scientific Corporation, Biotronik, and Merit Medical Systems, Inc.

Notably, Infinity Angioplasty Balloon Co in November 2020 announced the successful trial completion of its innovative angioplasty balloon platform named Infinity Angioplasty Balloon Catherer. The device was declared efficient to be used for treating various types of artery diseases.

Apart from that, other noteworthy players are also undertaking various strategies like mergers & acquisitions, collaboration deals, partnerships, innovative product launches, among others to strengthen their footprint in the overall market and garner significant returns.

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years’ data history and forecast.

• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.

• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.

• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions Answered in This Report:

How has the global Angioplasty Balloons market performed so far and how will it perform in the coming years?

What has been the impact of COVID-19 on the global Angioplasty Balloons market?

What are the key regional markets?

What is the breakup of the market based on the type?

What is the breakup of the market based on the product?

What is the breakup of the market based on the application?

What are the various stages in the value chain of the industry?

What are the key driving factors and challenges in the industry?

What is the structure of the global Angioplasty Balloons market and who are the key players?

What is the degree of competition in the industry?

About We Market Research

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

We Market Research

Phone: +1(929)-450-2887

Email: [email protected]

Web:

https://wemarketresearch.com/

#Angioplasty Balloons Market

0 notes

delicatemagazinedreamer · 2 years

Text

Peripheral Vascular Devices Market COVID-19 Analysis, Drivers, Restraints, Opportunities & Threats

Peripheral vascular devices are classified into peripheral stents grafts, angioplasty catheters, peripheral guidewires, vena cava filters, embolic projection devices, PTA balloons, and peripheral venous thrombectomy devices. The market for peripheral vascular stents and grafts is dominated by peripheral vascular stents and grafts. In the peripheral vascular devices market, the angioplasty catheter is the fastest growing segment.

Geographically, the peripheral vascular device market is divided. The Peripheral Vascular Devices Market is dominated by North America, followed by Europe. The Asia-Pacific region is expected to grow as the number of cases of peripheral vascular disease rises. Manufacturers of peripheral vascular devices are implementing key development strategies to create next-generation devices. A large number of clinical trials are being conducted to improve the safety and effectiveness of the drug.

Read more @ https://creativeedge16.blogspot.com/2022/04/global-peripheral-vascular-devices.html

0 notes

varsha582 · 3 years

Link

0 notes

vicky8588 · 3 years

Text

Angioplasty Balloons Market

Market Overview

The global "angioplasty balloons market" size was worth US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a high CAGR of XX % during the forecast period (2021-2028).

Angioplasty, also known as balloon angioplasty and percutaneous transluminal angioplasty (PTA), is a minimally invasive endovascular procedure used to restore blood flow through the artery by widening the narrowed or obstructed arteries. Angioplasty balloons are balloon-tipped catheters used to flatten the plaque against the artery wall during an angioplasty procedure.

Download Free Samples @ https://www.datamintelligence.com/download-sample/angioplasty-balloons-market

Market Dynamics

The global angioplasty balloons market growth is driven by the increasing burden of cardiovascular diseases, the preference toward minimally invasive surgery and increasing geriatric populations.

Increasing geriatric populations coupled with the increase in clinical development to advance the technologies are expected to drive the growth in the forecast period

The growing prevalence of lifestyle-related disorders and increasing geriatric populations fuel the growth of the angioplasty balloons market. For instance, according to the World Aging Population Report, in 2019, the number of people aged 65 years and above was recorded to be around 702.9 million globally, and the number is expected to reach 1548.9 million by 2050. Thus, with an increase in the geriatric population, the prevalence of chronic diseases, especially cardiovascular disease, is also expected to increase, resulting in hospital admissions and surgeries. Also, there has been an increase in clinical development to advance the existing technology and explore new opportunities by key players. For instance, in November 2018, Koninklijke Philips N.V. initiated patient enrolment for its Stellarex ILLUMINATE below-the-knee (BTK) investigational device exemption (IDE) and commenced clinical trial in the United States. The study was aimed to evaluate the safety and effectiveness of the Stellarex 0.014 drug-coated angioplasty balloon to percutaneous transluminal angioplasty (PTA) in critical limb ischemia (CLI) patients. These players are increasing their focus on more contemporary angioplasty balloons made of different materials and new products. They are coming up with new and innovative product launches to propel market growth.

High costs and the post-operational complications associated with angioplasty are likely to hamper the market growth

On average, the procedure, without any sort of health insurance, can cost anywhere from $25,000 to as much as $125,000 in the United States and the complications associated such as restenosis, heart attack, ventricular fibrillation, myocardial infarction, misplacement of a stent, aneurysms, kidney failure, seizures, occur within 6 to 10 hours of angioplasty performed. These factors are likely to hinder market growth.

COVID-19 Impact Analysis

As per a research article published in September 2020, cardiac surgery during the current COVID-19 pandemic carries a combined peril for both cardiac patients, who are now at a greater risk of experiencing complications due to COVID-19, and for the healthcare workers associated with these patients. In addition, the American College of Surgeons and the American Society of Anesthesiologists recommended suspending elective cardiac surgery for a minimum of 14 days after a patient test negative for COVID-19. Thus, given the several factors surrounding COVID-19, elective angioplasty surgeries are expected to be suspended, which is likely to affect the adoption of angioplasty balloons. The market can have slight or even very little growth during this period.

Segment Analysis

The hospital segment is expected to hold the largest share in this market segment

The hospital segment is expected to hold a significant share of the overall angioplasty balloons market. The factors responsible for the dominance of this segment are advanced healthcare infrastructure, increasing availability of skilled labor, and affordability. For instance, in 2018, as per the report published by Advanced Medical Technology Association (AdvaMed), India, the government's move to cap the maximum prices of various cardiovascular surgical instruments has resulted in reduced angioplasty procedure costs in tier 1 and metro corporate chains and standalone private hospitals up to 18% in the country, which is one of the major hubs of cardiovascular disease. In addition, the substantial growth in the geriatric population suffering from lifestyle diseases, such as atherosclerosis and heart failure, is expected to increase the patient pool and enhance revenue generations for the hospitals.

Moreover, compared to conventional surgeries, the several advantages of minimally invasive surgeries, such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and speedy recovery time, encourage an increasing number of patients to opt for minimally invasive balloon angioplasty surgeries. As per the data reported by the American College of Cardiology, approximately 1.2 million angioplasties are performed in a year in the United States. Moreover, hospitals' high accessibility and affordability, compared to the speciality clinics, are expected to attract a large patient population.

However, due to the current COVID-19 situation, limited movement of population in hospitals is being observed. Except for an emergency, people are keen to avoid undergoing surgery or diagnostic procedures to limit the risk of the COVID-19 infection. In addition, hospitals have also transferred their personnel availability from cardiac departments to other departments in need, such as EDs or intensive care units (ICU). All these factors are expected to affect the market growth. Nevertheless, this slow-down in growth is anticipated to be temporary, and in the long run, the market is expected to have significant growth.

Geographical Analysis

North America region holds the largest market share of the global angioplasty balloons market

North America accounted for a major revenue share in the angioplasty balloons market. The presence of key market players, the growing healthcare expenditure, and a rising number of percutaneous coronary interventions are the primary drivers of the market in the region. Also, according to the American Heart Association Research Report 2018, heart disease accounted for 1 in 7 deaths in the United States in that year. Among the cardiovascular diseases, coronary heart disease was the leading cause of death, accounting for 43.8% of deaths, followed by stroke (16.8%), heart failure (9.0%), high blood pressure (9.4%), diseases of the arteries (3.1 %), and other cardiovascular diseases (17.9%). Thus, higher demand for better treatment with advanced medical devices exists, a major factor driving the studied market.

Furthermore, the factors estimated to augment the market during the forecast years are increased investments and the inorganic growth strategies by major market players in the region. For instance, in 2018, Teleflex, a US-based company, signed an agreement to acquire the assets of QT Vascular. Under the agreement, Teleflex paid USD 98.4 million and USD 26.2 million for the non-drug-coated coronary products, USD 65.6 million for the drug-coated coronary product, and up to an additional USD 6.6 million upon the achievement of certain sales revenue milestones. All these developments are further expected to increase the robust product line of the market and are anticipated to offer lucrative growth opportunities to the market of this region.

View Full Report @ https://www.datamintelligence.com/research-report/angioplasty-balloons-market

Competitive Landscape

The global angioplasty balloons market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include BIOTRONIK, Medtronic Plc, Boston Scientific Corporation, Cordis (Cardinal Health), Terumo Corporation, Abbott Laboratories, AngioDynamics, Becton Dickinson, INFINITY Angioplasty Balloon, Koninklijke Philips N.V and Oscor Inc. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the calcium channel blocker globally. For instance, In January 2021, OrbusNeich Medical Co. Ltd received the United States Food and Drug Administration's (FDA's) clearance for its JADE 0.014”, 0.018” and 0.035” OTW non-compliant peripheral balloon dilatation catheter series. The JADE Percutaneous Transluminal Angioplasty (PTA) OTW Balloon Dilatation Catheter is an over-the-wire balloon catheter indicated for percutaneous transluminal angioplasty, including obstructed native arteries and synthetic arteriovenous dialysis fistulae.

Key Companies to Watch

Boston Scientific Corporation

Overview: The company was founded in 1979. it has headquarters in the United States. It develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology, and neuromodulation. Globally the company has business in the US, EMEA, Asia-Pacific, Latin America, and Canada.

Product Portfolio: It includes products like APEX PTCA Dilatation Catheter, Charger 0.035" Balloon Dilatation Catheter, Coyote and Coyote ES 0.014” Balloon Dilatation Catheter, Mustang 0.035” Balloon Dilatation Catheter, etc.

Ranger Paclitaxel-Coated PTA Balloon Catheter- It is backed by multiple level-1 randomized controlled trials, ranger provides exceptional outcomes, effortless deliverability, and efficient drug transfer.

For Enquiry @ https://www.datamintelligence.com/enquiry/angioplasty-balloons-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

#Drug Eluting Balloons Normal Balloons Cutting/Scoring Balloons

0 notes

market-reserch · 3 years

Link

0 notes

reportsandreports · 3 years

Text

PTA Balloon Catheters Market Report

The PTA Balloon Catheters Market research report analyzes global PTA Balloon Catheters Market status, future forecast, growth opportunity, key market, and key players. Its main perspective is defining, describing, and forecasting by type, market, and key regions. Furthermore, PTA Balloon Catheters Market report systematically highlights the key players and comprehensively analyzes their development plan and strategies. The information also helps understand the most affecting driving and restraining forces in the market and their impact on the global market.

Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4998920

0 notes

newsupdate-1 · 3 years

Text

Catheters Market Size, Growth, Emerging Trends And Forecast

According to a new report published by Polaris Market Research, the global catheters market is anticipated to reach USD 56.5 billion by 2025. In 2017, by product type, cardiovascular catheter segment captures the largest market shares in terms of revenue and hold major share in the market. Regionally, North America accounted for the major share in the catheter market.

Catheters are thin tubes made up of plastic, nylon, polyvinyl chloride (PVC), and silicon rubber. Catheters are majorly used in catheterization while surgical procedures like angioplasty, and neurosurgery. The catheters market is primarily driven by continuous growth in the population suffering from cardiovascular disorders and diabetes. Presently, various countries showed the growth in number of patients suffering from hypertension and diabetes which is braced by factors such as smoking, drinking and sedentary lifestyle of the population. In addition, favorable reimbursement policies, increasing demand for minimal invasive surgeries, and technological advanced catheter with high effectiveness by its use would spur the global catheter market during the forecast period. on other hand, the wide application of catheter in various surgeries such as angioplasty would also push this market. The reimbursements by the Medicaid program that provide approximately 100 catheters per month to add the growth of catheter market in the future.

Get Sample copy of this report : https://www.polarismarketresearch.com/industry-analysis/global-catheters-market/request-for-sample

Cardiovascular Catheters, holds a major share in the global catheter market. The cardiovascular catheter market is further segmented as PTCA balloon catheters, IVUS catheters, PTA balloon catheters, electrophysiological catheters, and others. The growth of cardiovascular catheters is majorly driven by the increasing incidences of cardiovascular diseases supporting the growth of cardiovascular interventional procedures. While, urological catheter holds the second largest segment with largest revenue. The factors contributing for the growth of urological market are continuous technological advancements, and increasing prevalence of urological diseases in the coming year.

Geographically, North America holds a dominating position in the global catheter market followed by Europe and Asia Pacific. The growth in the North America catheter market is driven by the presence of refined health infrastructure, high volume of catheterization in medical procedures, high healthcare expenditure by the individuals, and high level of patient awareness about the use catheters. Whereas, Asia Pacific is expected to reach remarkable growth owning to the increased penetration rate of these devices in the developing countries, growing technological advancements pertaining the development of new-catheter devices, and improving healthcare expenditure would influence the catheter market in Asia Pacific during the forecast period.

The leading companies operating in this industry include Johnson & Johnson Inc., Abbott Laboratories, Becton, Dickson and Company, B. Braun Melsungen AG., Medtronic plc., Boston Scientific Corporation, Cook Group Incorporated, Teleflex Incorporated, Cardinal Health Inc., Smiths Medical, Arrow International Inc., Edward Life Science Corporation, and Coloplast.

Key Findings from the study suggest products available in the market are continuously concentrating on the technological advancements that will reduce the side effects caused by the use of catheters. The leading companies while developing new products considers the factors such as increasing disposable income, and untapped market potential. North America is presumed to dominate the global catheter market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Request For Discount : https://www.polarismarketresearch.com/industry-analysis/global-catheters-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes